23.3 Percutaneous Coronary Intervention

Key Takeaways

  • Unfractionated heparin during PCI is monitored with activated clotting time. Confirm the ordered range and analyzer before interpreting the result.

  • Drug-eluting stents reduce restenosis compared with bare-metal stents. A trial percentage represents a particular device, endpoint and follow-up interval.

  • Rotational atherectomy modifies severely calcified plaque to help achieve adequate lesion preparation and stent expansion.

  • Suspect no-reflow when antegrade flow falls despite an open epicardial vessel after the team excludes a mechanical obstruction and epicardial spasm.

  • Coronary perforation can cause pericardial effusion and tamponade. Recognize extravascular contrast or sudden instability and alert the operator immediately.

Last updated: November 2026

23.3 Percutaneous Coronary Intervention

Workflow and Lesion Preparation

Percutaneous coronary intervention (PCI) uses a guiding catheter for support and a steerable coronary guidewire to cross the lesion. Before treatment, the team reviews lesion length and calcium, side branches, distal runoff and collateral supply. Those findings affect support, preparation and the landing zone for the device.

  • Balloon angioplasty dilates the lesion. Predilation can help deliver a stent and shows whether the lesion expands.
  • Scoring and cutting balloons concentrate the force of inflation with scoring elements or small cutting blades. They can help modify selected resistant lesions.
  • Rotational atherectomy uses a diamond-coated burr to modify calcified plaque. Other calcium-modification options include orbital atherectomy, laser in selected cases and intravascular lithotripsy. The operator selects the method based on lesion morphology, device compatibility and patient factors.

Stenting. A bare-metal stent mechanically scaffolds the lumen. A drug-eluting stent (DES) releases an antiproliferative drug to limit neointimal growth. In the historical RAVEL trial of a first-generation sirolimus-eluting stent for selected native lesions, 6-month binary restenosis was 0 of 109 compared with 29 of 109 (26.6%) in the standard-stent group with angiographic follow-up. Binary restenosis used a diameter narrowing of at least 50% as its endpoint. The numbers describe that trial. Modern coronary revascularization guidelines prefer DES over bare metal when stenting is performed.

Select a stent against the reference vessel and lesion length. The operator may use a noncompliant balloon to improve expansion and apposition. Review final images for residual narrowing, vessel flow, dissection and loss of a side branch. Intravascular ultrasound (IVUS) and optical coherence tomography (OCT) can help size and optimize stents and clarify problems that lumen images alone do not resolve.

Adjunctive Pharmacology

Unfractionated heparin (UFH) is commonly used to support PCI. The 2025 U.S. acute coronary syndromes (ACS) guideline lists a 250–300 second activated clotting time (ACT) target for UFH in its ACS PCI anticoagulant table. Follow the patient-specific order and local analyzer protocol. The reported ACT can vary by assay, and coadministration of a glycoprotein (GP) IIb/IIIa inhibitor changes some protocols. Bivalirudin is an alternative anticoagulant with its own monitoring. Verify the analyzer and the ordered target, relay the value promptly, and document sampling times, doses and repeat values.

Dual antiplatelet therapy (DAPT) combines aspirin with a P2Y12 inhibitor. The 2025 guideline defaults to at least 12 months after ACS in patients without high bleeding risk. Bleeding risk and a need for long-term oral anticoagulation can change the plan. Oral P2Y12 inhibitors include clopidogrel, prasugrel and ticagrelor. Prasugrel is contraindicated after prior stroke or transient ischemic attack. Intravenous cangrelor is a procedural option in selected patients. GP IIb/IIIa inhibitors may have a role in selected cases with large thrombus, slow flow or no-reflow.

Intraprocedural Complications

ComplicationRecognitionResponse to anticipate
Coronary dissectionNew linear flap or staining, flow loss, pain or ECG changesReport promptly. Flow-limiting injury can require stent coverage.
No-reflowDiminished antegrade flow despite an open epicardial vessel after exclusion of alternative causesReport flow and hemodynamics. After evaluation, the operator can deliver an arteriolar vasodilator to the distal bed and support perfusion pressure.
Coronary perforationExtravascular crater, staining or contrast jet. New hypotension may signal tamponade.Alert the team and prepare for balloon occlusion, rescue equipment, and evaluation for pericardial effusion. Definitive treatment depends on the location and severity.
Abrupt closureSudden occlusion or flow loss within the treated segmentIdentify the mechanism. The operator may restore patency with rewiring, balloon treatment or additional stenting.
Side-branch compromiseLoss of flow into a branch after treating the main vesselReport the changed branch and compare with baseline. The response depends on the vessel and the territory at risk.

No-reflow reflects microvascular impairment. Distal embolization, edema and spasm may contribute. In primary PCI for ST-elevation myocardial infarction, the SCAI consensus calls for assessing other causes, such as dissection, and then considers distal arteriolar vasodilators and improved coronary perfusion pressure. Epicardial spasm or residual thrombus can also mimic a flow problem. IVUS or OCT can help when the operator suspects a structural cause, but imaging choice depends on the case.

The Ellis classification separates an extraluminal crater without extravasation (type I), myocardial or pericardial blush (type II), and a frank contrast jet (type III). Document new contrast staining and vital-sign changes. A proximal perforation may require a covered stent and a distal wire perforation may call for embolization. Tamponade can require urgent pericardial drainage. The team individualizes anticoagulation management and escalation.

References

Test Your Knowledge

Which ACT target does the 2025 U.S. acute coronary syndromes guideline list in its anticoagulant table for unfractionated heparin supporting PCI?

A

120–150 seconds

B

180–200 seconds

C

250–300 seconds

D

400–500 seconds

Test Your Knowledge

During primary PCI for ST-elevation myocardial infarction, the treated epicardial artery is open but distal flow is markedly slow. The operator has excluded dissection, residual obstruction and epicardial spasm. Which action fits suspected microvascular no-reflow?

A

Deploy a covered stent for presumed perforation.

B

Reverse heparin to improve distal perfusion.

C

Prepare pericardial drainage based on slow flow alone.

D

Prepare to support distal intracoronary arteriolar vasodilator delivery and coronary perfusion pressure.

Sections you finish are checked off in the contents.